Michael A. Younkins

Michael A. Younkins serves as a procurement professional responsible for managing acquisitions in the biological products manufacturing sector, with a singular focus on the NAICS code 325414—Biological Product (except Diagnostic) Manufacturing. His role centers on ensuring the timely and compliant procurement of critical biological substances, including vaccines, therapeutics, and other advanced biologics essential to public health and national security missions. He oversees the full lifecycle of contract actions, from market research and solicitation development to award and performance monitoring, aligning acquisitions with federal regulatory standards and scientific requirements. His expertise lies in navigating the complex regulatory and technical landscape of biomanufacturing, ensuring that procurements meet stringent quality, safety, and scalability benchmarks. While no specific contractor relationships are identifiable due to limited data, his procurement activity suggests engagement with specialized biopharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), and firms with current Good Manufacturing Practice (cGMP) certification. He likely collaborates with vendors possessing advanced bioprocessing capabilities, including cell culture, purification, and aseptic fill-finish operations, often requiring significant technical vetting and supply chain resilience. Younkins’ contracting patterns reflect a complete absence of set-aside preferences, with 100% of awards issued under full and open competition. This indicates a strategic emphasis on technical capability and production capacity over socioeconomic categorization, prioritizing mission-critical outcomes and supply chain reliability. His domain expertise is narrowly concentrated in biological product manufacturing, encompassing monoclonal antibodies, recombinant proteins, and other live or inactivated biological agents. He is deeply familiar with the technical specifications, regulatory compliance frameworks, and manufacturing validation protocols unique to this high-stakes sector, ensuring procurements support public health readiness and biodefense objectives.